Veterinary Medicines

Kefavet® vet 250 mg, film-coated tablet

Authorised
  • Cefalexin monohydrate
Download as PDF

Product identification

Medicine name:
Kefavet® vet 250 mg, film-coated tablet
Active substance:
  • Cefalexin monohydrate
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Cefalexin monohydrate
    263.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Film-coated tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01DB01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Luxembourg
Package description:
  • Blister, 28 tablets
  • Blister, 70 tablets
  • Blister, 140 tablets
  • Blister, 14 tablets
  • Blister, 20 tablets

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Orion Corporation
Marketing authorisation date:
Manufacturing sites for batch release:
  • Orion Oyj / Orion Corporation / Orion Pharma
Responsible authority:
  • Ministry Of Health And Social Security
Authorisation number:
  • V 225/11/01/1046
Date of authorisation status change:
Reference member state:
  • Sweden
Procedure number:
  • SE/V/0114/001
Concerned member states:
  • Belgium
  • Czechia
  • Denmark
  • Estonia
  • Hungary
  • Iceland
  • Latvia
  • Lithuania
  • Luxembourg
  • Netherlands
  • Poland
  • Romania
  • Slovakia
  • Slovenia

Documents

Package Leaflet

English (PDF)
Published on: 17/04/2025
Download

Summary of Product Characteristics

English (PDF)
Published on: 17/04/2025
Download

Labelling

English (PDF)
Published on: 17/04/2025
Download